Austrian researchers have successfully developed a new electrophoretic method for detecting MIRCERA® and other erythropoietins (EPO) in the blood. The technique, using SARCOSYL-PAGE, has specifically ...

-- Dose Adjustments Considered to be one of the Main Causes of Haemoglobin Instability in Chronic Kidney Disease Patients A new analysis has shown that once-monthly Mircera(R) maintains stable ...

Human therapeutics company Amgen has succeeded in preventing rival Roche from launching its anaemia drug Mircera in the US, after a jury in the US Federal District Court in Boston found that the drug ...

The World Anti-doping Agency (WADA) has been working with drug makers to develop new tests for potential performance enhancing drugs before they can make their way into the peloton, the agency ...

Rather than banking on its future royalties of Cimzia and Mircera, Nektar Therapeutics Inc. cashed them in for $124 million to pay down its $215 million convertible debt that comes due in September.

ZURICH, April 13 (Reuters) - Swiss drugmaker Roche's experimental medicine Mircera is safe and effective for the treatment of renal anaemia associated with chronic kidney disease, pooled data from ...

Roche Holding AG was barred by an appeals court on Friday from selling the anemia drug Mircera in the United States, after a judge found that the company infringes Amgen Inc.’s patents. The U.S. Court ...

BOSTON U.S. District Judge William Young has ordered Amgen and Roche to submit a list of names for an expert to be appointed to their trial regarding the release of Roche’s anemia drug, Mircera, in ...

ZURICH, Oct 16 (Reuters) - Roche Holding AG's Mircera anaemia drug is probably on track for U.S. approval with a similar label to that in Europe, the head of its pharmaceuticals business said. "The ...